NCT02420444 A Study for Safety and Immunogenicity of BCG and AERAS-404 in HIV-Negative, TB-Negative, BCG-Naive Adults Status COMPLETED Phase PHASE1
NCT02415985 Pharmacokinetics and Safety of Rifabutin 150 mg Once Daily Versus Rifabutin 300 mg Thrice Weekly Status COMPLETED Phase PHASE2
NCT02414828 A Study to Evaluate the Safety of AERAS-402 in Adults Recently Treated for Pulmonary TB Status COMPLETED Phase PHASE2
NCT02413502 Leukapheresis Sampling for Immune Responses After BCG Vaccination in BCG-naïve Healthy Adults in the US Status COMPLETED Phase EARLY_PHASE1
NCT02412436 PK Study of Rifampicin Interactions With DMPA and Efavirenz in TB Status COMPLETED Phase PHASE2
NCT02410772 TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens Status COMPLETED Phase PHASE3
NCT02393586 Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Faropenem Plus Amoxicillin/Clavulanic Acid in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02391415 Study to Evaluate the Safety and Immunogenicity of VPM1002 in Comparison With BCG in HIV-exposed/-Unexposed Newborn Infants in South Africa Status COMPLETED Phase PHASE2
NCT02389322 Phase IIb Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 on Healthy People Aged 18-65 Status COMPLETED Phase PHASE2
NCT02387242 Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Rifampicin in Healthy Volunteers Status SUSPENDED Phase PHASE1
NCT02383849 IMPAACT P1106: Pharmacokinetic Characteristics of Antiretrovirals and Tuberculosis Medicines in Low Birth Weight Infants Status COMPLETED Phase N/A
NCT02382107 A Blinded, Cross-sectional, Diagnostic Evaluation Study Performed in Pulmonary TB Suspects at the TB Dispensary for Sector 4 of the Marius-Nasta-Institute in Bucharest, Romania Status COMPLETED Phase N/A
NCT02378207 Safety and Immunogenicity Study of BCG, H4:IC31, and H56:IC31 Revaccination in Healthy Adolescents Status COMPLETED Phase PHASE1
NCT02375698 A Phase I Study of Safety & Immunogenicity of AERAS-456 in HIV-Neg. Adults Treated for Drug-susceptible Pulmonary TB Status COMPLETED Phase PHASE1
NCT02375256 A Leukapheresis Study for Immune Responses in Healthy US Adults Who Receive BCG Vaccination Followed by Boosting With AERAS-402 Status COMPLETED Phase PHASE1
NCT02355223 Finding and Treating Unsuspected and Resistant TB to Reduce Hospital Transmission Status UNKNOWN Phase NA
NCT02348177 Pharmacokinetics of Lopinavir/Ritonavir Superboosting in Infants and Young Children Co-infected With HIV and TB Status COMPLETED Phase PHASE4
NCT02337270 Phase 1 Clinical Trial of the Safety and Immunogenicity of an Adenovirus-based TB Vaccine Administered by Aerosol Status COMPLETED Phase PHASE1
NCT02336542 Phase IIb Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 Status COMPLETED Phase PHASE2